|
⚲
|
| Keyboard |
| Caspian Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002156247 |
| Sale | 2026-09-08 (50.0 M Offered, 50.0 M Sold) |
| Fund | |
| Phone | 8585008800 |
| Address | 4930 Directors Place San Diego, CA 92121 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-09-23 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Spike Loy | Director | |
| Troy Wilson | Director | |
| Robert Spencer | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Institutional Venture Management XVII LLC
✚
|
CA | |
|
The Social Capital Partnership LLC
✚
|
CA | |
|
Otherwise Fund Management LLC
✚
|
CA | |
|
Bullpen Management LLC
✚
|
CA | |
|
Type One Management LLC
✚
|
CA | |
|
Hanabi Capital Management LLC
✚
|
CA | |
|
Liquid 2 Ventures LLC
✚
|
CA | |
|
Canvas Management Company LLC
✚
|
CA | |
|
Good Friends LLC
✚
|
CA | |
|
MNS Global Capital Managers LLC
✚
|
CA |